
Day 2 Recap: Winter Clinical Miami 2026
Key Takeaways
- Real-world prescribing patterns indicate tildrakizumab is frequently selected for plaque psoriasis in older patients with medically complex comorbidities.
- Case-based atopic dermatitis advances include pediatric topical innovations, refined interpretation of JAK safety signals, and lesion-directed strategies for head-and-neck involvement.
Catch up on coverage from the second day of Winter Clinical Miami 2026.
To stay informed with the latest conference insights, follow us on social media and
New Data Shows Tildrakizumab Frequently Prescribed for Older, Comorbid Plaque Psoriasis Patients
A poster presented at Winter Clinical Miami 2026 shows tildrakizumab is often preferred for older patients with plaque psoriasis and medically complex comorbidities.
Rein in the Inflammation: April Armstrong, MD, MPH’s Case-Based Update on AD Innovation
April Armstrong, MD, MPH, spotlights new pediatric topicals and JAK safety insights, plus targeted options for head-and-neck atopic dermatitis.
Linda Stein Gold, MD, FAAD, on the Evolving Landscape of Acne, Rosacea, and Psoriasis
At Winter Clinical Miami 2026, Linda Stein Gold, MD, FAAD, shared acne and rosacea tips and previewed psoriasis oral advances like icotrokinra.
Intralesional Cemiplimab Shows Promise as a Non-Surgical Alternative for Early-Stage CSCC
A WCM poster highlights intralesional cemiplimab for early CSCC, showing rapid responses and positive safety versus surgery.
Harrison Nguyen, MD, MBA, MPH, FAAD’s Roadmap for the Early Career Clinician
Harrison Nguyen, MD, MBA, MPH, FAAD, shares early career billing, coding, and mentorship tips for dermatologists at Winter Clinical Miami 2026.
For more insights from Winter Clinical and beyond, check out our














